Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
10/2001
10/04/2001EP0855999B1 1-(1,2-disubstituted piperidinyl)-4-substituted piperidine derivatives as tachykinin receptor antagonists
10/04/2001EP0741712B1 Process for making hiv protease inhibitors
10/04/2001EP0730581B1 3-acylaminobenzazepines
10/04/2001EP0698013B1 Fungicidal fused bicyclic pyrimidinones
10/04/2001EP0631575B1 Substituted pyrimidines and their use as pesticides
10/04/2001EP0613465B1 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents
10/04/2001DE19947154A1 Substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use
10/04/2001DE10015248A1 Bisamidino-Verbindungen als NHE-3 Inhibitoren Bisamidino compounds as NHE-3 inhibitors
10/04/2001CA2404662A1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
10/04/2001CA2404626A1 Novel piperazine derivatives
10/04/2001CA2401242A1 Pharmaceutically active pyrrolidine derivatives
10/04/2001CA2399864A1 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases
10/03/2001CN1315950A Dihydrobenzodioxine carboxamide and ketone derivatives as 5-HT4 receptor antagonists
10/03/2001CN1315949A Salts of paroxetine
10/03/2001CN1315948A Naphthopyrans annelated in C5-C6, their preparation and compositions and (CO) polymer matrices containing them
10/03/2001CN1315943A Use of 5-amino-pyrazol-derivatives for combating micro-organisms
10/03/2001CN1315830A Treatment of anxiety disorders
10/03/2001CN1072226C 1(2H) quinoline carboxylic acid derivatives, method for preparing same, and use thereof for synthesising substances having antibiotic
10/03/2001CN1072221C 3-halo-3-heteroaryl carboxylic acid derivatives, method of preparing them and intermediates
10/02/2001US6297382 Compound and process for producing β-adrenergic receptor agonist
10/02/2001US6297381 Inhibit the release of inflammatory cytokines such as interleukin-1 and tumor necrosis factor, ureas or thioureas substituted by a pyrrole or thiophene
10/02/2001US6297374 Nitroimino-nitromethylene—azole or-azine heterocyclic compounds, insecticidal compositions containing them, and insecticidal methods of using them
10/02/2001US6297277 Cysteine protease inhibitors containing heterocyclic leaving groups
10/02/2001US6297269 Substituted n-(indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors
10/02/2001US6297261 Potent chloride channel blockers; treatment of sickle cell anemia, brain edema following ischaemia or tumors, diarrhea, hypertension (diuretic), osteoporosis, and for the reduction of the intraocular pressure
10/02/2001US6297259 Substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl)butyl) benzamides useful for the treatment of allergic diseases
10/02/2001US6297233 Lactam inhibitors of FXa and method
10/02/2001CA2212451C Stereoselective and useful preparation of 3-substituted 4-aryl piperidine compounds
10/02/2001CA2156908C C9 taxane derivatives and pharmaceutical compositions containing them
10/02/2001CA2037541C Azabicyclo and azacyclo oxime and amine cholinergic agents and methods of treatment
09/2001
09/30/2001CA2342571A1 Process for preparing substituted pyridines
09/27/2001WO2001070737A2 Therapeutic heterocyclic compounds for the treatment of asthma and allergy and use thereof
09/27/2001WO2001070734A2 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
09/27/2001WO2001070731A1 Decahydro-isoquinolines
09/27/2001WO2001070727A1 2-(arylalkylamino)pyrimidone derivatives and 2-(heteroarylalkylamino)pyrimidone derivatives
09/27/2001WO2001070706A2 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents
09/27/2001WO2001070696A1 Nitroethenamine derivatives or salts thereof and pharmaceutical compositions containing the derivatives or the salts
09/27/2001WO2001070690A1 Heterocyclic side chain containing metalloprotease inhibitors
09/27/2001WO2001070673A2 CYCLIC β-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES AND TNF-$g(a)
09/27/2001WO2001070232A1 Protease inhibitors
09/27/2001WO2001070228A1 Antagonists of gonadotropin releasing hormone
09/27/2001WO2001034632A3 Aliphatic hydroxy substituted piperidyl diaryl pyrrole derivatives as antiprotozoal agents
09/27/2001WO2001032654A3 Novel heterocyclic compounds and their use as medicines
09/27/2001WO2001004134A3 Novel esters derived from nucleosides, preparation methods and pharmaceutical compositions containing them
09/27/2001WO2001004115A3 Novel process for synthesis of heteroaryl-substituted urea compounds
09/27/2001WO2000061541A3 Pharmaceutical compounds
09/27/2001WO2000061537A3 Pharmaceutical compounds
09/27/2001US20010025108 Thrombosis diseases
09/27/2001US20010025052 Novel nitric oxide-releasing amidine- and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same
09/27/2001US20010025043 New pharmaceutical active compounds
09/27/2001US20010024749 Surface modified carbonaceous materials
09/27/2001US20010023877 Inverted aerosol dispenser
09/27/2001DE10014761A1 New N-halophenyl-pyrazole and N-pyridyl-pyrazole derivatives useful as broad spectrum, selective herbicides
09/27/2001DE10014006A1 New heterocyclic acylsulfimide derivatives, useful as insecticides, acaricides and nematocides for plant protection or in veterinary medicine
09/27/2001CA2404206A1 Protease inhibitors
09/27/2001CA2404076A1 Heterocyclic side chain containing metalloprotease inhibitors
09/27/2001CA2401870A1 Cyclic .beta.-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-.alpha.
09/27/2001CA2400168A1 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
09/27/2001CA2400000A1 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents
09/26/2001EP1136491A1 2-[(Heteroaryl)alkylamino]pyrimidone derivatives
09/26/2001EP1136490A1 New forms of paroxetin hydrochloride
09/26/2001EP1136484A1 2-(Arylalkylamino)pyrimidone derivatives
09/26/2001EP1136477A1 Benzofuran derivatives, process for the preparation of the same and uses thereof
09/26/2001EP1136099A1 2-(Indolylalkylamino)pyrimidone derivatives as GSK3beta inhibitors
09/26/2001EP1135384A1 Process for the production of paroxetine hydrochloride propan-2-ol solvate
09/26/2001EP1135383A1 Mixed paroxetine propan-2-ol solvates
09/26/2001EP1135382A1 Method of producing paroxetine hydrochloride
09/26/2001EP1135374A1 Benzimidazole compounds that are vitronectin receptor antagonists
09/26/2001EP1135371A1 Beta-alanine derivatives as alpha 4 integrin inhibitors
09/26/2001EP1135370A2 Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds
09/26/2001EP1135239A1 Wood preservative formulations
09/26/2001EP1135130A1 Use of prucalopride for the manufacture of a medicament for the treatment of dyspepsia
09/26/2001EP1135119A1 Glucose and lipid lowering compounds
09/26/2001EP0833825B1 6-carboxamido dihydropyran derivatives
09/26/2001CN1314906A Salts of paroxetine
09/26/2001CN1314905A Muscarinic antagonists
09/26/2001CN1314351A Process for synthesizing quinazolone and quinazolone compound with anti-cancer function
09/26/2001CN1314345A Novel piperidine-4-sulfamide compound, its preparing method and medicinal composition containing them
09/26/2001CN1071757C Pyrazol benzoyl derivatives
09/26/2001CN1071755C Heterocyclyycarboxamide derivatives and their use as therapeutic agents
09/25/2001US6294674 Dibenzofuran sulfonamide matrix metalloproteinase inhibitors
09/25/2001US6294580 For therapy and prophylaxis of type ii or non-insulin dependent diabetes mellitus, hyperglycaemia, dyslipidemia, type ii diabetes, type i diabetes, hypertriglyceridemia, syndrome x, insulin resistance, heart failure
09/25/2001US6294574 Compounds and methods for the treatment of inflammatory and immune disorders
09/25/2001US6294569 Analgesic at central nervous system in the mammalian subject. also, these compounds are inflammatory pain caused, for example by burns (induced by a contact with heat, acid or the other rheumatism or the like, in the said subject.
09/25/2001US6294565 Treatment of leukemia by administering a bisimidazole thiophene
09/25/2001US6294564 Benzimidazoles and benzoxazoles
09/25/2001US6294558 Antiinflammatory agents and prostaglantins
09/25/2001US6294557 Analgesic at central nervous system in the mammalian subject. also, these compounds are inflammatory pain caused, for example by burns (induced by a contact with heat, acid or the other rheumatism or the like, in the said subject.
09/25/2001US6294555 1-[(1-Substituted-4-piperidinyl)methyl]-4-piperidine derivative, process for producing the same, medicinal compositions containing the same and intermediates of these compounds
09/25/2001US6294554 Muscarinic antagonists
09/25/2001US6294551 N-linked sulfonamides of heterocyclic thioesters
09/25/2001US6294517 Compositions and kits comprising alpha-adrenergic receptor antagonists and nitric oxide donors and methods of use
09/25/2001US6294112 Red coloring hyperchromic 3H-naphtho[2,1-B]pyrans
09/25/2001CA2029132C Sulphonylaminocarbonyltriazolinones having substituents which are bonded via sulphur
09/20/2001WO2001068652A1 Condensed imidazoles as histamine h3 receptor ligands
09/20/2001WO2001068651A1 Condensed imidazoles as histamine h3 receptor ligands
09/20/2001WO2001068641A1 6-aminoalkyl-dihydropyrimidines and the use thereof as medicaments against viral diseases
09/20/2001WO2001068633A1 2-phenylpyran-4-one derivatives
09/20/2001WO2001068614A2 5-substituted arylpyrimidines
09/20/2001WO2001068607A1 Amide compounds and use thereof
1 ... 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 ... 694